Actavis Reaches Deal With Pfizer To Sell Generic Celebrex
Actavis PLC said Thursday it has reached an agreement with Pfizer Inc. to end all outstanding patent litigation over the arthritis drug Celebrex, paving the way for the Ireland-based pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article